 |
|
|
| |
Successful Retreatment With Sofosbuvir-containing Regimens for HCV Genotype 2 or 3 Infected Patients who Failed Prior Sofosbuvir Plus Ribavirin Therapy
|
| |
| |
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Rafael Esteban1, Lisa Nyberg2, Jay Lalezari3, Liyun Ni4, Brian Doehle4, Bittoo
Kanwar4, Diana Brainard4, GM Subramanian4, William T. Symonds4, John G.
McHutchison4, Maribel Rodriquez-Torres5, Stefan Zeuzem6
1Vall d'Hebron Hospital, Barcelona, Spain; 2Kaiser Permanente, San Diego, CA, USA; 3Quest Clinical Research, San Francisco, CA, USA; 4Gilead Sciences, Inc., Foster City, CA, USA; 5Fundacion de Investigacion, San Juan, Puerto Rico; 6JW Goethe University Hospital, Frankfurt, Germany
|
| |
|
|
|
|
|
